Effects of nisoldipine on myocardial ischemia during exercise and during daily activity.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  American Journal of Cardiology

• Publication date

  1991-03-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9149(91)90891-NPMID 2000786
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute and chronic hemodynamic effects of nisoldipine in essential hypertension at rest and during exercise.

  2009cited by this paper
• A comparison of the acute hemodynamic effects of nifedipine and nisoldipine in patients with ischemic reduced left ventricular function

  2004cited by this paper
• The pharmacodynamics and pharmacokinetics of a new calcium antagonist nisoldipine in normotensive and hypertensive subjects

  2004cited by this paper
• The Nifedipine-Total Ischemia Awareness Program: a national survey of painful and painless myocardial ischemia including results of antiischemic therapy.

  1989cited by this paper
• Effect of the second-generation calcium channel blocker nisoldipine on left ventricular contractility in cardiac failure.

  1988cited by this paper
• Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment.

  1988cited by this paper
• Characteristics of silent and symptomatic myocardial ischemia during daily activities.

  1988cited by this paper
• Clinical significance of exercise-induced silent myocardial ischemia in patients with coronary artery disease.

  1987cited by this paper
• Efficacy of nisoldipine combined with beta‐adrenergic‐blocking drugs in the treatment of chronic stable angina

  1987cited by this paper
• The haemodynamic significance of asymptomatic ST segment depression assessed by ambulatory pulmonary artery pressure monitoring.

  1986cited by this paper
• Myocardial ischemia during daily activities and stress.

  1986cited by this paper
• Effect of propranolol on indices of intermittent myocardial ischemia, assessed by exercise testing and ambulatory st‐segment monitoring

  1986cited by this paper
• Mechanisms and therapy of silent myocardial ischemia: the effect of transdermal nitroglycerin.

  1986cited by this paper
• Coronary and systemic hemodynamic effects of intravenous nisoldipine.

  1986cited by this paper
• Calcium-blocker withdrawal phenomenon: increase in affinity of alpha 2 adrenoceptors for agonist as a potential mechanism.

  1986cited by this paper
• Holter recording during treadmill testing in assessing myocardial ischemic changes.

  1985cited by this paper
• Double-blind double-dummy crossover study of the efficacy and safety of nisoldipine (BAYk5552) versus nifedipine

  1985cited by this paper
• Acute effects of intravenous nisoldipine on left ventricular function and coronary hemodynamics.

  1985cited by this paper
• Improvement in exercise performance with nisoldipine, a new second-generation calcium blocker, in stable angina patients.

  1985cited by this paper
• [Comparison of the anti-ischemia effect of nisoldipine and verapamil. Double-blind randomized cross-over and placebo-controlled acute and long-term study].

  1984cited by this paper
• Treatment of angina pectoris with nifedipine: importance of dose titration.

  1983cited by this paper
• Vasodilator profile of a new 1,4-dihydropyridine derivative, 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)]-ethyl ester 5-methyl ester hydrochloride (YC-93).

  1976cited by this paper
• [Pharmacology of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (Nifedipine, BAY a 1040)].

  1972cited by this paper

• Current status of calcium channel blockers in patients with cardiovascular disease.

  1999cites this paper
• Protective effect of nisoldipine on dipyridamole‐induced myocardial ischemia: correlation with exercise electrocardiography

  1998cites this paper
• Efficacy and Tolerability of Nisoldipine Coat-Core vs Diltiazem Retard in Combination with a Beta-Blocker in Patients with Stable Exertional Angina Pectoris

  1998cites this paper
• Assessment of ischemic changes by ambulatory ECG-monitoring: comparison with 12-lead ECG during exercise testing.

  1997cites this paper
• Clinical application of three-dimensional myocardial imaging: Evaluation of efficacy of medical treatment on myocardial perfusion

  1996cites this paper
• Comparison between metoprolol orally osmotic once daily and metoprolol two or three times daily in suppressing exercise-induced and daily myocardial ischemia.

  1996cites this paper
• Effects of nisoldipine in silent myocardial ischemia after healing of acute myocardial infarction.

  1995cites this paper
• [Myocardial ischemia detected by Holter monitoring: analysis of therapeutical trials realised in stable angina].

  1995cites this paper
• Effects of amlodipine on transient myocardial ischaemia in patients with a severe coronary condition treated with a beta-blocker. Amlor-Holter Study Investigators.

  1995cites this paper
• Synergistic effect of nisoldipine and nitroglycerin on human internal mammary artery.

  1994cites this paper
• Improvement of ischemic myocardial dysfunction by nisoldipine

  1994cites this paper
• Circadian Variations in Ischemic Threshold and Their Relation to the Occurrence of Ischemic Episodes

  1993cites this paper
• [Dose-response relationship of nisoldipine in patients with stable angina pectoris and stress-induced myocardial ischemia].

  1993cites this paper
• Proischemic complications of dihydropyridine calcium channel blockers.

  1991cites this paper
• Variations in Ischemic Threshold During Daily Activities

  1991cites this paper